| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/11/2002 | WO2002028410A1 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002006789A3 Multimeric biopolymers as structural elements, sensors and actuators in microsystems |
| 04/11/2002 | WO2002006511A3 Methods for detecting and assaying nucleic acid sequences |
| 04/11/2002 | WO2002004915A3 Device and method for molecular detection |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002001218A3 Non-thermosensitive medium for analysing species inside a channel |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001098747A3 Agonist versus antagonist binding to g protein-coupled receptors |
| 04/11/2002 | WO2001096877A3 Rare earth metal cryptates showing reduced fluorescence quenching |
| 04/11/2002 | WO2001096871A3 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore |
| 04/11/2002 | WO2001096383A3 High fluorescent intensity cross-linked allophycocyanin |
| 04/11/2002 | WO2001094946A9 Microarrays for performing proteomic analyses |
| 04/11/2002 | WO2001094638A8 Asynchronous primed pcr |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001091629A3 Methods for detecting dna damage and screening for cancer therapeutics |
| 04/11/2002 | WO2001090312A9 Ammonia-oxidizing bacteria |
| 04/11/2002 | WO2001089298A3 Compositions and methods of nematode control |
| 04/11/2002 | WO2001088544A3 Proteolytic enzymes in diagnosis of kidney disorders |
| 04/11/2002 | WO2001088517A3 Gas sensors with improved resistance to humidity interference |
| 04/11/2002 | WO2001086285A3 Direct detection of individual molecules |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001084146A3 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001081627A3 N-silico-screening for docking on sub-domain iiid of hcv-ires |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001075150A3 Biosensor, biosensor array, method for producing an electrode of a biosensor, method for producing a biosensor |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001073432A3 Method for detecting and/or quantifying first molecules |
| 04/11/2002 | WO2001073430A3 Identification, assessment, prevention and therapy of cancers |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070814A3 Regulation of human rta-like g protein-coupled receptor |
| 04/11/2002 | WO2001069256A3 Sensor element for optically detecting chemical or biochemical analytes |
| 04/11/2002 | WO2001067106A3 Identification of g protein-coupled receptor ligands and modulators |
| 04/11/2002 | WO2001067067A3 Method and apparatus for preparing cytological specimens |
| 04/11/2002 | WO2001067062A3 Analysis of biological and/or chemical mixtures using magnetic particles |
| 04/11/2002 | WO2001066000A3 Health analysis and forecast of abnormal conditions |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2001063294A3 Diagnosis of bipolar affective disorder (bad) and unipolar depression |
| 04/11/2002 | WO2001063285A3 Method for detecting helicobacter pylori and heilmanii |
| 04/11/2002 | WO2001061325A3 Biochemical blocking layer for liquid crystal assay |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001059153A3 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 04/11/2002 | WO2001053835A3 Methods for detecting cancer of the central nervous system |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001051673A8 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 04/11/2002 | WO2001044818A3 Method for determining parathormone activity in a human sample |
| 04/11/2002 | WO2001037231A8 Carbon monoxide detector for air vehicles |
| 04/11/2002 | WO2001020532A3 Method and means for data management in a laboratory |
| 04/11/2002 | WO2001019405A3 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 04/11/2002 | WO2001011372A9 Annexins and autoantibodies used as markers for cancer |
| 04/11/2002 | WO2000075237A3 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS |
| 04/11/2002 | WO2000063689A9 Detecting and suppressing malignancy based on expression of spleen tyrosine kinase (syk) |
| 04/11/2002 | WO2000055373A3 Methods of screening for macrophage development modulators |
| 04/11/2002 | WO2000052463A9 Method of diagnosing and monitoring malignant breast carcinomas |
| 04/11/2002 | WO2000052210A3 Methods for targeting rna molecules |
| 04/11/2002 | WO2000052048A9 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 04/11/2002 | WO2000049409A9 ASSAY FOR THE IDENTIFICATION OF IgE ANTIBODY SUPPRESSORS |
| 04/11/2002 | WO2000047996A9 Arrays comprising a fiducial and automated information processing in randomly ordered arrays |
| 04/11/2002 | WO2000047762A9 Enriched central nervous system cell populations |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042785 Neural network assisted multi-spectral segmentation system |
| 04/11/2002 | US20020042689 Method and apparatus for evaluation of aggregate particle shapes through multiple ratio analysis |
| 04/11/2002 | US20020042686 Residual chlorine meter and residual chlorine measuring method |
| 04/11/2002 | US20020042681 Characterization of phenotypes by gene expression patterns and classification of samples based thereon |
| 04/11/2002 | US20020042679 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains |
| 04/11/2002 | US20020042545 Asymmetric oxidation of olefins to vicinal diol using osmium catalyst |
| 04/11/2002 | US20020042389 IGF-1 receptor interacting proteins |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042360 Antitumor agents |
| 04/11/2002 | US20020042359 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 04/11/2002 | US20020042335 Method and apparatus for making density gradients |
| 04/11/2002 | US20020042149 Analyzing preferential particles in bodily fluid; obtain sample, incubate with binding particles, detect bound particles |
| 04/11/2002 | US20020042146 Method for assay of analyte by adjustment of chemiluminescence |
| 04/11/2002 | US20020042145 Liquid sample assay device |
| 04/11/2002 | US20020042144 Preventing agglomeration of bodily fluid; obtain body fluid sample, incubate with enzyme inhibitors, monitor body fluid agglomeration |
| 04/11/2002 | US20020042143 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 04/11/2002 | US20020042142 Solution concentration measuring method and solution concentration measuring apparatus |
| 04/11/2002 | US20020042125 Isolation of preferential particles from fluid; obtain sample, force sample through passageway, force elution fluid through passageway, release particle from the solid support into the elution fluid, recover particles |
| 04/11/2002 | US20020042121 Method for measuring the association of substructures of pathological protein depositions |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042100 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042092 Measurement of microbiological activity in an opaque medium |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042088 Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020042085 Produce light energy when decomposed; stable at room temperature |
| 04/11/2002 | US20020042084 Enzymatic reaction of a substrate radiolabelled at the C-terminal glutamate group detected by its binding to fluomicrospheres |
| 04/11/2002 | US20020042083 Measuring activity and identifying modulators of ubiquitin ligase enzymes |
| 04/11/2002 | US20020042082 Diagnostic detection device and method |
| 04/11/2002 | US20020042081 Evaluating binding affinities by force stratification and force panning |
| 04/11/2002 | US20020042080 Detecting position of label in polypeptides; degrade polypeptide, measure amount of label, calibrate with amino acid sequence of the polypeptide detect position of label |
| 04/11/2002 | US20020042079 Monitoring development of drug resistance tumor cells; obtain cells, screen segments for defects in vesicular transfer, no defects in vesicular transfer indicate drug resistance in tumor cells |
| 04/11/2002 | US20020042075 Sample presentation apparatus for mass spectrometry |